Pediatrix Medical Group Inc (MD)

NYSE · Healthcare · Medical Care Facilities · USA

Pediatrix Medical Group Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Care Facilities industry.

Pediatrix Medical Group provides physician services across neonatal, maternal-fetal, and pediatric subspecialty care through a network of affiliated physicians operating nationwide. The company staffs and manages neonatal intensive care units, provides care to mothers with complicated pregnancies, and offers pediatric intensive care, hospitalist services, and surgical care. Pediatrix also operates a newborn hearing screening program across hospitals.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Pediatrix Medical Group Inc stock.

Our verdict on MD

Slightly undervalued: intrinsic value $35.30 per share, market price $31.13, margin of safety 11.8% (as of 2026-11-17).

Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $35.30; the price of $31.13 is 12% below that value, and 79% of that value comes from beyond year five.

ETFs with the most weight in MD

17 more funds hold it; the full list is part of the paid plan.

More on MD

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than MD in Medical Care Facilities

9 more in this industry show a wider margin of safety.

Is MD undervalued or overvalued?

MD is slightly undervalued (as of the 2026-11-17 close). Discounting its cash flows at 7.9% (average of 3 methods) values the shares at $35.30; the price of $31.13 is 12% below that value, and 79% of that value comes from beyond year five.

What is the intrinsic value of MD?

$35.30 per share (as of the 2026-11-17 close), against a market price of $31.13. That is a margin of safety of 11.8%. The value is the average of the 3 valuation methods that apply to this company, recomputed every night after the US close.